Yuxi Luo

机构：Nanchang University, Guiyang Medical University, Xiamen University, First Affiliated Hospital of Jiangxi Medical College, Jiangsu University of Science and Technology, Jiangxi Provincial Cancer Hospital, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Guizhou Medical University, Peking University Shenzhen Hospital, Kunming Institute of Precious Metals, Collaborative Innovation Center of Chemistry for Energy Materials · ORCID：0000-0003-4963-8526

发表论文 43 篇 · 总被引 556 次 · h-index 13

代表论文

• Oncostatin M/Oncostatin M Receptor Signal Induces Radiation-Induced Heart Fibrosis by Regulating SMAD4 in Fibroblast (2023 · International Journal of Radiation Oncology*Biology*Physics · 被引 23)
• Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study (2022 · BMC Cancer · 被引 21)
• Tuning CO 2 Electrocatalytic Reduction Path for High Performance of Li‐CO 2 Battery (2024 · Advanced Functional Materials · 被引 18)
• Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy (2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 17)
• Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study (2025 · Cancer Immunology Immunotherapy · 被引 13)
• Integrated multi-omics reveals glycolytic gene signatures of lung adenocarcinoma brain metastasis and the impact of Rac2 lactylation on immunosuppressive microenvironment (2025 · Journal of Translational Medicine · 被引 9)